CLOS
IPXL

Compagnie Lombard Odier SCmA’s Impax Laboratories, Inc. IPXL Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Hold
0
– – – 278
2015
Q2 		– Sell
-4,296
Closed -$201K – 971
2015
Q1 		$201K Sell
4,296
-5,358
-56% -$213K 0.01% 489
2014
Q4 		$306K Sell
9,654
-8,939
-48% -$262K 0.01% 342
2014
Q3 		$441K Buy
18,593
+3,013
+19% +$77.2K 0.02% 351
2014
Q2 		$467K Buy
+15,580
New +$420K 0.02% 342

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Compagnie Lombard Odier SCmA's IPXL Position: Q4 2015 in Review

Compagnie Lombard Odier SCmA held its Impax Laboratories, Inc. (IPXL) position steady in Q4 2015 at 0 shares worth $683K. The position accounts for 0.02% of the portfolio, ranked #278.

Compagnie Lombard Odier SCmA first reported a position in IPXL in Q2 2014 and has held it in 4 quarters since. The position peaked at $467K in Q2 2014. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

  • Compagnie Lombard Odier SCmA held 0 shares of Impax Laboratories, Inc. worth $683K as of Q4 2015.
  • Compagnie Lombard Odier SCmA left its Impax Laboratories, Inc. share count unchanged in Q4 2015.
  • Impax Laboratories, Inc. made up 0.02% of Compagnie Lombard Odier SCmA's portfolio in Q4 2015, its #278 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Impax Laboratories, Inc. in Q2 2014 and has held it in 4 quarters since.
  • Compagnie Lombard Odier SCmA's Impax Laboratories, Inc. position peaked at $467K in Q2 2014.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2015, filed 16 Feb 2016.